• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多唾液酸苷与硫酸化类似物相比,在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)结合方面表现更优。

Polysialosides Outperform Sulfated Analogs for Binding with SARS-CoV-2.

作者信息

Khatri Vinod, Boback Nico, Abdelwahab Hassan, Niemeyer Daniela, Palmer Tahlia M, Sahoo Anil Kumar, Kerkhoff Yannic, Ludwig Kai, Heinze Julian, Balci Dilara, Trimpert Jakob, Haag Rainer, Povolotsky Tatyana L, Netz Roland R, Drosten Christian, Lauster Daniel C, Bhatia Sumati

机构信息

Freie Universität Berlin, Institute of Chemistry and Biochemistry, Takustr. 3, 14195, Berlin, Germany.

Department of Chemistry, TDL Govt. College for Women Murthal, Sonipat, Haryana, 131027, India.

出版信息

Small. 2025 Aug;21(34):e2500719. doi: 10.1002/smll.202500719. Epub 2025 Jul 16.

DOI:10.1002/smll.202500719
PMID:40665883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393028/
Abstract

Both polysialosides and polysulfates are known to interact with the receptor binding domain (RBD) of the SARS-CoV-2 spike protein. However, a comprehensive site by site analysis of their binding affinities and potential synergistic antiviral effects have not been performed. Here, we report on the synthesis of polysialosides with nanomolar binding affinities to spike proteins of SARS-CoV-2 in solution using microscale thermophoresis. The dendritic polyglycerol based polysialosides dPGSA and dPGSA, with a dissociation constant K of 4.78 nm and 10.85 nm, respectively, bind ≈500 times stronger than the high density polysulfated analog dPGS, to intact SARS-CoV-2 virus particles or isolated spike protein. In fact, the presence of sulfate groups in a heteromultivalent compound dPGSAS weakens the binding to spike proteins. A polycarboxylated analog does not bind to SARS-CoV-2, ruling out that the interaction of polysialoside is simply driven by electrostatics. Using explicit-solvent all-atom molecular dynamics simulations and ensemble docking studies, atomistic details are obtained on the interaction of different functional groups with the SARS-CoV-2 RBD. The data support the conclusion that sialosides interact stronger than sulfates for their binding with RBD of SARS-CoV-2. Notably, the most affine binder dPGSA inhibits SARS-CoV-2 (WT, D614G) replication up to 98.6% at 0.5 µm concentrations.

摘要

已知多唾液酸苷和多硫酸盐都能与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的受体结合域(RBD)相互作用。然而,尚未对它们的结合亲和力和潜在的协同抗病毒作用进行全面的逐位点分析。在此,我们报告了使用微量热泳技术在溶液中合成与SARS-CoV-2刺突蛋白具有纳摩尔结合亲和力的多唾液酸苷。基于树枝状聚甘油的多唾液酸苷dPGSA和dPGSA,解离常数K分别为4.78纳米和10.85纳米,与完整的SARS-CoV-2病毒颗粒或分离的刺突蛋白结合的强度比高密度多硫酸化类似物dPGS强约500倍。事实上,杂多价化合物dPGSAS中硫酸根的存在会削弱其与刺突蛋白的结合。一种多羧化类似物不与SARS-CoV-2结合,排除了多唾液酸苷的相互作用仅仅由静电驱动的可能性。通过显式溶剂全原子分子动力学模拟和整体对接研究,获得了不同官能团与SARS-CoV-2 RBD相互作用的原子细节。数据支持以下结论:唾液酸苷与SARS-CoV-2的RBD结合时比硫酸盐相互作用更强。值得注意的是,亲和力最高的结合剂dPGSA在浓度为0.5微摩尔时可抑制SARS-CoV-2(野生型、D614G)复制达98.6%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/95e1f7c72a05/SMLL-21-2500719-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/310adb4fb18b/SMLL-21-2500719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/a6f1bd951275/SMLL-21-2500719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/4ad6b67ee610/SMLL-21-2500719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/fe8694acb055/SMLL-21-2500719-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/7895df9cf870/SMLL-21-2500719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/95e1f7c72a05/SMLL-21-2500719-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/310adb4fb18b/SMLL-21-2500719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/a6f1bd951275/SMLL-21-2500719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/4ad6b67ee610/SMLL-21-2500719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/fe8694acb055/SMLL-21-2500719-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/7895df9cf870/SMLL-21-2500719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c19/12393028/95e1f7c72a05/SMLL-21-2500719-g005.jpg

相似文献

1
Polysialosides Outperform Sulfated Analogs for Binding with SARS-CoV-2.多唾液酸苷与硫酸化类似物相比,在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)结合方面表现更优。
Small. 2025 Aug;21(34):e2500719. doi: 10.1002/smll.202500719. Epub 2025 Jul 16.
2
Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent.利用刺突蛋白受体结合域开发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其奥密克戎变种的适配体,作为一种潜在的诊断工具和治疗剂。
Biomolecules. 2025 Jun 1;15(6):805. doi: 10.3390/biom15060805.
3
Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.海洋硫酸化聚糖抑制肝素与新冠病毒奥密克戎XBB变体S蛋白的相互作用。
Glycoconj J. 2024 Apr;41(2):163-174. doi: 10.1007/s10719-024-10150-1. Epub 2024 Apr 20.
4
Corticosteroid Prednisolone and flavonoid Chrysin as drug candidates against SARS-CoV-2 replication: Computational and experimental findings.皮质类固醇泼尼松龙和类黄酮白杨素作为抗SARS-CoV-2复制的候选药物:计算和实验结果。
Microb Pathog. 2025 Oct;207:107923. doi: 10.1016/j.micpath.2025.107923. Epub 2025 Jul 25.
5
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式,并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.
6
Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.SARS-CoV-2 感染个体在针对刺突糖蛋白的抗体反应的域特异性和相对效力方面存在有限的变异性。
Microbiol Spectr. 2022 Feb 23;10(1):e0267621. doi: 10.1128/spectrum.02676-21. Epub 2022 Jan 26.
7
Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern.新冠病毒变异株刺突蛋白的 N 糖基化和 O 糖基化位点特异性分析。
Sci Rep. 2023 Jun 21;13(1):10053. doi: 10.1038/s41598-023-33088-0.
8
A Rationally Designed Synthetic Antiviral Peptide Binder Targeting the Receptor-Binding Domain of SARS-CoV-2.一种针对 SARS-CoV-2 受体结合域的理性设计的合成抗病毒肽结合物。
J Phys Chem B. 2024 May 16;128(19):4631-4645. doi: 10.1021/acs.jpcb.4c00241. Epub 2024 Apr 24.
9
Molecular Mechanism of Anti-SARS-CoV-2 Activity of Ephedra Herb Macromolecule Condensed-Tannin Contained in Ephedrine Alkaloids-Free Ephedra Herb Extract.不含麻黄碱生物碱的麻黄草提取物中麻黄草大分子缩合单宁抗SARS-CoV-2活性的分子机制
Chem Pharm Bull (Tokyo). 2025;73(7):621-626. doi: 10.1248/cpb.c25-00191.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD.蛋白质-聚电解质结合热力学的定量预测:肝素类似物多硫酸盐对严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的吸附
JACS Au. 2025 Jan 6;5(1):204-216. doi: 10.1021/jacsau.4c00886. eCollection 2025 Jan 27.
2
Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection.树枝状聚合物的超分子结构提供不可逆抑制剂以阻断病毒感染。
Adv Mater. 2025 Jan;37(3):e2408294. doi: 10.1002/adma.202408294. Epub 2024 Sep 30.
3
Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid.
单分子成像揭示宿主唾液酸对新冠病毒刺突受体结合域的变构刺激作用。
Sci Adv. 2024 Jul 19;10(29):eadk4920. doi: 10.1126/sciadv.adk4920. Epub 2024 Jul 17.
4
Two Receptor Binding Strategy of SARS-CoV-2 Is Mediated by Both the N-Terminal and Receptor-Binding Spike Domain.两种 SARS-CoV-2 受体结合策略均由 N 端和受体结合刺突结构域介导。
J Phys Chem B. 2024 Jan 18;128(2):451-464. doi: 10.1021/acs.jpcb.3c06258. Epub 2024 Jan 8.
5
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.吸入型 ACE2 诱饵可预防临床前模型中的 SARS-CoV-2 感染。
Sci Transl Med. 2023 Aug 30;15(711):eadi2623. doi: 10.1126/scitranslmed.adi2623.
6
Respiratory viruses interacting with cells: the importance of electrostatics.呼吸道病毒与细胞的相互作用:静电作用的重要性。
Front Microbiol. 2023 Jun 27;14:1169547. doi: 10.3389/fmicb.2023.1169547. eCollection 2023.
7
Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain.研究唾液酸衍生物作为 SARS-CoV-2 刺突蛋白受体结合域潜在抑制剂的研究。
J Biomol Struct Dyn. 2024 Aug;42(12):6342-6358. doi: 10.1080/07391102.2023.2234044. Epub 2023 Jul 9.
8
Dual-Action Heteromultivalent Glycopolymers Stringently Block and Arrest Influenza A Virus Infection and .双功能杂化多价糖聚合物严格阻断和抑制甲型流感病毒感染。
Nano Lett. 2023 Jun 14;23(11):4844-4853. doi: 10.1021/acs.nanolett.3c00408. Epub 2023 May 23.
9
Structural and energetic analyses of SARS-CoV-2 -terminal domain characterise sugar binding pockets and suggest putative impacts of variants on COVID-19 transmission.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)末端结构域的结构和能量分析确定了糖结合口袋,并提示了变异体对新型冠状病毒肺炎(COVID-19)传播的潜在影响。
Comput Struct Biotechnol J. 2022;20:6302-6316. doi: 10.1016/j.csbj.2022.11.004. Epub 2022 Nov 7.
10
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.SARS-CoV-2 变异株 Alpha 在 ACE2 表达水平较低的人类细胞中相对于原始 B.1 株具有依赖 Spike 的复制优势。
PLoS Biol. 2022 Nov 16;20(11):e3001871. doi: 10.1371/journal.pbio.3001871. eCollection 2022 Nov.